These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4631815)

  • 1. [In-vitro action of rifampicin on strains of tuberculous and atypical mycobacteria].
    Denis-Bottin C
    Acta Tuberc Pneumol Belg; 1972; 63(1):127-39. PubMed ID: 4631815
    [No Abstract]   [Full Text] [Related]  

  • 2. "In vitro" action of rifampicin on typical and atypical mycobacteria.
    Tanzil HO; Chatim A; Rachim A; Judanarso D
    Acta Tuberc Pneumol Belg; 1972; 63(1):140-7. PubMed ID: 4631816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
    Mandler F; Garimoldi M
    G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin sensitivity of mycobacteria].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 8. [The activity of Rifampicin in vitro on atypical mycobacteria].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 May; 22(5):498-506. PubMed ID: 4975206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
    Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of isoniazid and rifampicin on viability and ultrastructure of M. tuberculosis].
    Gulevskaia SA; Milovanova EV
    Probl Tuberk; 1977 May; (5):67-73. PubMed ID: 406613
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of the Genotype MTBDR assay directly on sputum specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):1057-9. PubMed ID: 16964801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro].
    Woźniak S; Tomaszkiewicz L; Zierski M
    Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.